Although KLK7 has been described as a biomarker in many types of cancers (Devetzi et al., 2013; Kryza et al., 2016; Walker et al., 2014), to our knowledge, this is the first report demonstrating a role for KLK7 in the metastatic process of melanoma. This evidence concerns the gene KLK7 and cancer.